Supplemental Materials: The Spectrum of Cutaneous and Systemic Manifestations Associated with Anti-PM/Scl
Published: 23 December 2024| Version 1 | DOI: 10.17632/nc3jwdy55c.1
Contributor:
Sabrina SDescription
This document includes detailed methodologies for testing, criteria for disease classification, and definitions of organ involvement. Three supplemental tables present systemic manifestations, laboratory and serological testing results, and clinical characteristics of anti-PM/Scl-positive patients across different autoimmune connective tissue diseases.
Files
Categories
Dermatology, Rheumatology, Connective Tissue Disorder